Cellectar Biosciences Inc (CLRB)

[stockforme]

Why do you think this is oversold. I was thinking of buying in now, but after looking at the last 10Q, it says their whole business is dependent on the phase 3 getting passed.

The completion of the Phase 3 clinical trial is likely to significantly affect the Company’s ability to finance
continued operations beyond the third quarter of 2010. If the results are favorable, the Company believes it will be able to obtain adequate funding to pursue its strategic objectives and clinical development programs longer term. If the results of the Phase 3 clinical trial are not favorable, the Company may be unable to obtain additional funding, and may be required to scale back administrative activities and clinical development programs, or cease its operations entirely. Furthermore, adverse conditions in the capital markets globally may impair the Company’s ability to obtain funding in a timely manner.